Cyclacel Pharmaceuticals, Inc. (CYCC) has 82 open-market insider trades by 19 insiders since 2006. The most active filer is Stanley Morgan, 10%.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Stanley Morgan | 10% | — | 24 | $14.0M | 2009-11-10 |
| David E. Lazar | 10% Owner | — | 2 | $11.8M | 2025-07-30 |
| Austin W. & Greenhouse David M. Marxe | 10% | — | 13 | $3.9M | 2011-09-23 |
| Portfolio Services Ltd. | 10% Owner | — | 1 | $1.7M | 2017-07-19 |
| Jean Deleage | — | — | 1 | $723K | 2006-12-01 |
| TANG Capital Partners L.P. | 10% Owner | — | 1 | $582K | 2017-02-23 |
| Spiro George Rombotis | Pres | — | 16 | $522K | 2023-12-21 |
| Khai Loon Kua | 10% Owner | — | 1 | $267K | 2025-09-05 |
| Deerfield Special Situations Fund, L.P. via James E. Flynn | 10% | — | 1 | $146K | 2008-11-14 |
| Management Co /ny Deerfield | 10% | — | 1 | $121K | 2008-11-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Khai Loon Kua | 10% Owner | Sell | $267K | 2025-09-05 |
| David E. Lazar | 10% Owner | Sell | $83K | 2025-07-30 |
| David E. Lazar | CEO | Sell | $11.7M | 2025-02-26 |
| Spiro George Rombotis | President | Buy | $20K | 2023-12-21 |
| Paul McBarron | — | Buy | $6K | 2023-12-21 |
| Sam L. Barker | Director | Sell | $43 | 2021-11-30 |
Companies that share insiders with CYCC, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Spiro George Rombotis | President | Buy | $18K | 2021-11-18 |
| Sam L. Barker | Director | Buy | $5K | 2021-08-24 |
| Portfolio Services Ltd. | 10% Owner | Buy | $1.7M | 2017-07-19 |
| TANG Capital Partners L.P. | 10% Owner | Buy | $582K | 2017-02-23 |
| Sam L. Barker | Director | Buy | $9K | 2014-11-20 |
| Spiro George Rombotis | President | Buy | $300K | 2013-05-21 |
| Lloyd Sems | Director | Buy | $100K | 2013-05-21 |
| Paul McBarron | COO & CFO +2 | Buy | $39K | 2013-05-21 |
| Spiro George Rombotis | President | Buy | $8K | 2011-12-23 |